REYATAZ Side Effects

7019838-X | Coronary Artery Disease, Lipodystrophy Acquired, Renal Failure Acute
on Sep 27, 2010 Male patient from FRANCE , 73 years of age, weighting 138.9 lb, was diagnosed with acquired immunodeficiency syndrome and was treated with Reyataz (View Usage). Patient experienced the following unwanted or unexpected effects: coronary artery disease (What is coronary artery disease?), lipodystrophy acquired, renal failure acute. Reyataz dosage: . During the same period patient was treated with ISENTRESS (Tabs) (View Isentress Review and Isentress Label ).

7017374-8 | Ventricular Septal Defect
Patient was taking Reyataz (View Usage). Patient had the following side effects: ventricular septal defect on Sep 23, 2010 from IRELAND Additional patient health information: Male patient , weighting 6.61 lb, . Reyataz dosage: . During the same period patient was treated with NORVIR (View Norvir Review and Norvir Label ), EPZICOM (View Epzicom Review and Epzicom Label ), HEROIN (View Heroin Review and Heroin Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ).

6992211-6 | Hepatitis
Adverse event was reported on Sep 13, 2010 by a Male patient taking Reyataz (View Usage) (Dosage: ) . Location: FRANCE , 21 years of age, After Reyataz was administered, patient had the following side effects: hepatitis (What is hepatitis?). During the same period patient was treated with TRUVADA (View Truvada Review and Truvada Label ), NORVIR (View Norvir Review and Norvir Label ).

6988611-0 | Caesarean Section, Live Birth, Pregnancy
on Sep 07, 2010 Female patient from UNITED KINGDOM , 26 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Reyataz (View Usage). Patient experienced the following unwanted or unexpected effects: caesarean section, live birth, pregnancy (What is pregnancy?). Reyataz dosage: . During the same period patient was treated with TRUVADA (Tablet.) (View Truvada Review and Truvada Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ).


6988564-5 | Anuria, Nephrolithiasis
on Sep 08, 2010 Male patient from FRANCE , 45 years of age, was treated with Reyataz (View Usage). Patient had the following side effects: anuria, nephrolithiasis. Reyataz dosage: Duration:2-3 Years.

6987478-4 | Mycobacterium Avium Complex Infection, Viral Load Increased
Patient was taking Reyataz (View Usage). After Reyataz was administered, patient had the following side effects: mycobacterium avium complex infection, viral load increased on Sep 07, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 43 years of age, . Reyataz dosage: . During the same period patient was treated with KIVEXA (View Kivexa Review and Kivexa Label ), MOXIFLOXACIN (View Moxifloxacin Review and Moxifloxacin Label ), ETHAMBUTOL HYDROCHLORIDE (Morning) (View Ethambutol Hydrochloride Review and Ethambutol Hydrochloride Label ), RIFABUTIN (View Rifabutin Review and Rifabutin Label ), HALOPERIDOL (View Haloperidol Review and Haloperidol Label ), SEPTRIN (View Septrin Review and Septrin Label ).

6975462-6 | Cerebellar Syndrome, Encephalopathy, Hyperammonaemia
Adverse event was reported on Sep 01, 2010 by a Male patient taking Reyataz (View Usage) (Dosage: 1 Df = 2 Units Nos) was diagnosed with hiv infection (What is hiv infection?), thyroidectomy and. Location: FRANCE , 48 years of age, Patient experienced the following unwanted or unexpected effects: cerebellar syndrome, encephalopathy, hyperammonaemia. During the same period patient was treated with TRUVADA (1 Df =1 Units Nos) (View Truvada Review and Truvada Label ), NORVIR (1 Df = 1 Units Nos) (View Norvir Review and Norvir Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), AVLOCARDYL (View Avlocardyl Review and Avlocardyl Label ). Patient was hospitalized.

6973103-5 | Calculus Ureteric, Nephrolithiasis, Renal Colic
on Sep 08, 2010 Male patient from FRANCE , 40 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Reyataz (View Usage). Patient had the following side effects: calculus ureteric, nephrolithiasis, renal colic. Reyataz dosage: . During the same period patient was treated with NORVIR (View Norvir Review and Norvir Label ), KIVEXA (View Kivexa Review and Kivexa Label ).

6971255-4 | Hepatomegaly, Renal Colic
on Aug 31, 2010 Female patient from FRANCE , 34 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Reyataz (View Usage). After Reyataz was administered, patient had the following side effects: hepatomegaly, renal colic. Reyataz dosage: . During the same period patient was treated with NORVIR (View Norvir Review and Norvir Label ), TRUVADA (View Truvada Review and Truvada Label ). Patient was hospitalized.

6971239-6 | Acute Myocardial Infarction, Angina Unstable
Patient was taking Reyataz (View Usage). Patient experienced the following unwanted or unexpected effects: acute myocardial infarction, angina unstable on Aug 30, 2010 from JAPAN Additional patient health information: Male patient , 40 years of age, was diagnosed with hiv infection (What is hiv infection?), hyperlipidaemia, myocardial infarction and. Reyataz dosage: Initiated On 13jan05-21jul05 Duration :190 Days. During the same period patient was treated with NORVIR (Initiated On 13jan05-21jul05 Duration :190 Days 200mg:21oct05-1apr09 100mg:2apr09-ong) (View Norvir Review and Norvir Label ), TRUVADA (View Truvada Review and Truvada Label ), LEXIVA (Tab) (View Lexiva Review and Lexiva Label ), PRAVASTATIN SODIUM (Tab) (View Pravastatin Sodium Review and Pravastatin Sodium Label ), SIGMART (View Sigmart Review and Sigmart Label ), BUFFERIN (Tab) (View Bufferin Review and Bufferin Label ), PLAVIX (Tab) (View Plavix Review and Plavix Label ), OLMETEC (Tab) (View Olmetec Review and Olmetec Label ). Patient was hospitalized.

6969144-4 | Calculus Ureteric, Nephrolithiasis, Renal Colic
Adverse event was reported on Aug 31, 2010 by a Male patient taking Reyataz (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: FRANCE , 40 years of age, Patient had the following side effects: calculus ureteric, nephrolithiasis, renal colic. During the same period patient was treated with NORVIR (View Norvir Review and Norvir Label ), KIVEXA (View Kivexa Review and Kivexa Label ).

6967610-9 | Renal Colic
on Aug 31, 2010 Male patient from FRANCE , 43 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Reyataz (View Usage). After Reyataz was administered, patient had the following side effects: renal colic. Reyataz dosage: . During the same period patient was treated with NORVIR (View Norvir Review and Norvir Label ), KIVEXA (View Kivexa Review and Kivexa Label ). Patient was hospitalized.

6966771-5 | Cytolytic Hepatitis, Renal Colic
on Aug 31, 2010 Male patient from FRANCE , 37 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Reyataz (View Usage). Patient experienced the following unwanted or unexpected effects: cytolytic hepatitis, renal colic. Reyataz dosage: . During the same period patient was treated with NORVIR (View Norvir Review and Norvir Label ), TRUVADA (View Truvada Review and Truvada Label ), PREZISTA (View Prezista Review and Prezista Label ). Patient was hospitalized.

6966769-7 | Renal Colic
Patient was taking Reyataz (View Usage). Patient had the following side effects: renal colic on Aug 31, 2010 from FRANCE Additional patient health information: Male patient , 27 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Reyataz dosage: . During the same period patient was treated with NORVIR (View Norvir Review and Norvir Label ), TRUVADA (View Truvada Review and Truvada Label ). Patient was hospitalized.

6966739-9 | Cholangitis, Cholelithiasis, Cholestasis, Pancreatitis
Adverse event was reported on Aug 31, 2010 by a Male patient taking Reyataz (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: FRANCE , 66 years of age, After Reyataz was administered, patient had the following side effects: cholangitis, cholelithiasis, cholestasis, pancreatitis. During the same period patient was treated with NORVIR (View Norvir Review and Norvir Label ), TRUVADA (View Truvada Review and Truvada Label ).

6962771-X | Bronchopulmonary Dysplasia, Developmental Delay
on Aug 25, 2010 Male patient from GERMANY , weighting 2.20 lb, was treated with Reyataz (View Usage). Patient experienced the following unwanted or unexpected effects: bronchopulmonary dysplasia, developmental delay. Reyataz dosage: . During the same period patient was treated with TRUVADA (View Truvada Review and Truvada Label ), NORVIR (View Norvir Review and Norvir Label ).

6962766-6 | Premature Labour, Premature Rupture Of Membranes, Twin Pregnancy, Urinary Tract Infection
on Aug 25, 2010 Female patient from GERMANY , 30 years of age, was treated with Reyataz (View Usage). Patient had the following side effects: premature labour, premature rupture of membranes, twin pregnancy, urinary tract infection (What is urinary tract infection?). Reyataz dosage: 1 Df:300/. During the same period patient was treated with TRUVADA (View Truvada Review and Truvada Label ), NORVIR (Also May-2004 Until Oct-2006.) (View Norvir Review and Norvir Label ). Patient was hospitalized.

6958078-7 | Nephrolithiasis, Sepsis
Patient was taking Reyataz (View Usage). After Reyataz was administered, patient had the following side effects: nephrolithiasis, sepsis (What is sepsis?) on Aug 26, 2010 from BRAZIL Additional patient health information: Female patient , 46 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Reyataz dosage: . During the same period patient was treated with BIOVIR (View Biovir Review and Biovir Label ), KALETRA (View Kaletra Review and Kaletra Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ). Patient was hospitalized.

6958027-1 | Renal Failure Acute
Adverse event was reported on Aug 26, 2010 by a Female patient taking Reyataz (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: UNITED STATES , 46 years of age, Patient experienced the following unwanted or unexpected effects: renal failure acute. During the same period patient was treated with PRAVACHOL (View Pravachol Review and Pravachol Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), LOPINAVIR/RITONAVIR (View Lopinavir/ritonavir Review and Lopinavir/ritonavir Label ), TENOFOVIR (View Tenofovir Review and Tenofovir Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), LANTUS (1 Dosage Form=1 Day) (View Lantus Review and Lantus Label ). Patient was hospitalized.

6955339-2 | Psychotic Disorder, Somnolence
on Aug 25, 2010 Female patient from UNITED STATES , 45 years of age, was diagnosed with hiv infection (What is hiv infection?), psychotic disorder (What is psychotic disorder?), parkinson's disease (What is parkinson's disease?), irritability, insomnia and was treated with Reyataz (View Usage). Patient had the following side effects: psychotic disorder (What is psychotic disorder?), somnolence. Reyataz dosage: . During the same period patient was treated with STOCRIN (View Stocrin Review and Stocrin Label ), COMBIVIR (19-oct-2009 To 12-feb-2010 And From 12-feb-2010 To 18-feb-2010 And Also From 10feb-18-feb-2010-cont) (View Combivir Review and Combivir Label ), EPIVIR (View Epivir Review and Epivir Label ), RETROVIR (View Retrovir Review and Retrovir Label ), HALOPERIDOL (View Haloperidol Review and Haloperidol Label ), PROMETHAZINE (18feb10:14mar (25d) 7apr10:cont) (View Promethazine Review and Promethazine Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ).

6941072-X | Myocardial Infarction
on Aug 20, 2010 Male patient from FRANCE , 43 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Reyataz (View Usage). After Reyataz was administered, patient had the following side effects: myocardial infarction. Reyataz dosage: . During the same period patient was treated with NORVIR (View Norvir Review and Norvir Label ), KIVEXA (1df=600mg/300mg, 1 Film-coated Tablet.) (View Kivexa Review and Kivexa Label ). Patient was hospitalized.

6936898-2 | Renal Failure Acute
Patient was taking Reyataz (View Usage). Patient experienced the following unwanted or unexpected effects: renal failure acute on Aug 17, 2010 from UNITED STATES Additional patient health information: Female patient , 46 years of age, . Reyataz dosage: . During the same period patient was treated with TENOFOVIR (View Tenofovir Review and Tenofovir Label ), NORVIR (View Norvir Review and Norvir Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ). Patient was hospitalized.

6936892-1 | Eyelid Oedema, Malaise, Nausea, Rash
Adverse event was reported on Aug 16, 2010 by a Male patient taking Reyataz (View Usage) (Dosage: Interrupted On 12jul2010; Reyataz (atazanavir 300mg Tablets)) was diagnosed with hiv infection (What is hiv infection?), antibiotic prophylaxis and. Location: BRAZIL , 57 years of age, Patient had the following side effects: eyelid oedema, malaise, nausea (What is nausea?), rash (What is rash?). During the same period patient was treated with RITONAVIR (View Ritonavir Review and Ritonavir Label ), BIOVIR (View Biovir Review and Biovir Label ), BACTRIM (View Bactrim Review and Bactrim Label ).

6933535-8 | Nephrolithiasis, Renal Colic, Renal Failure Acute
on Aug 13, 2010 Male patient from FRANCE , 57 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Reyataz (View Usage). After Reyataz was administered, patient had the following side effects: nephrolithiasis, renal colic, renal failure acute. Reyataz dosage: . During the same period patient was treated with NORVIR (View Norvir Review and Norvir Label ), EMTRIVA (View Emtriva Review and Emtriva Label ), VIREAD (View Viread Review and Viread Label ), CRIXIVAN (Many Years) (View Crixivan Review and Crixivan Label ). Patient was hospitalized.

6933522-X | Nephrolithiasis, Postrenal Failure
on Aug 13, 2010 Male patient from FRANCE , 55 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Reyataz (View Usage). Patient experienced the following unwanted or unexpected effects: nephrolithiasis, postrenal failure. Reyataz dosage: . During the same period patient was treated with NORVIR (View Norvir Review and Norvir Label ), KIVEXA (1 Dosage Form = 1(units Not Specified)) (View Kivexa Review and Kivexa Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ). Patient was hospitalized.

6933521-8 | Blood Glucose Increased, Cellulitis
Patient was taking Reyataz (View Usage). Patient had the following side effects: blood glucose increased, cellulitis (What is cellulitis?) on Aug 16, 2010 from UNITED STATES Additional patient health information: Female patient , 52 years of age, . Reyataz dosage: . During the same period patient was treated with SUSTIVA (View Sustiva Review and Sustiva Label ), METFORMIN HCL (Dose Increased) (View Metformin Hcl Review and Metformin Hcl Label ), ALLORIL (View Alloril Review and Alloril Label ), PREVACID (View Prevacid Review and Prevacid Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), VALTREX (View Valtrex Review and Valtrex Label ), EPZICOM (View Epzicom Review and Epzicom Label ).

6933110-5 | Cytolytic Hepatitis
Adverse event was reported on Aug 13, 2010 by a Female patient taking Reyataz (View Usage) (Dosage: ) . Location: FRANCE , 21 years of age, After Reyataz was administered, patient had the following side effects: cytolytic hepatitis. During the same period patient was treated with TRUVADA (Tabs;1df:200 Mg/245 Mg) (View Truvada Review and Truvada Label ), NORVIR (1 Capsule) (View Norvir Review and Norvir Label ).

6932596-X | Nephrolithiasis, Renal Failure Acute, Suicidal Ideation
on Aug 13, 2010 Male patient from UNITED STATES , 49 years of age, was treated with Reyataz (View Usage). Patient experienced the following unwanted or unexpected effects: nephrolithiasis, renal failure acute, suicidal ideation. Reyataz dosage: . During the same period patient was treated with EPZICOM (View Epzicom Review and Epzicom Label ), TENOFOVIR (View Tenofovir Review and Tenofovir Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), VALTREX (View Valtrex Review and Valtrex Label ), KEPPRA (View Keppra Review and Keppra Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CYMBALTA (View Cymbalta Review and Cymbalta Label ). Patient was hospitalized.

6931960-2 | Caesarean Section, Live Birth, Pregnancy
on Aug 16, 2010 Female patient from IRELAND , 30 years of age, weighting 216.1 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Reyataz (View Usage). Patient had the following side effects: caesarean section, live birth, pregnancy (What is pregnancy?). Reyataz dosage: Course:1. During the same period patient was treated with NORVIR (View Norvir Review and Norvir Label ), EPZICOM (1df:1tabs.course:1) (View Epzicom Review and Epzicom Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), HEROIN (View Heroin Review and Heroin Label ).

6928561-9 | Caesarean Section, Live Birth, Pregnancy
Patient was taking Reyataz (View Usage). After Reyataz was administered, patient had the following side effects: caesarean section, live birth, pregnancy (What is pregnancy?) on Aug 11, 2010 from IRELAND Additional patient health information: Female patient , 30 years of age, weighting 216.1 lb, was diagnosed with hiv infection (What is hiv infection?) and. Reyataz dosage: . During the same period patient was treated with NORVIR (View Norvir Review and Norvir Label ), EPZICOM (1df:1tabs) (View Epzicom Review and Epzicom Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), HEROIN (View Heroin Review and Heroin Label ).

6923910-X | Nephrolithiasis
Adverse event was reported on Jun 02, 2010 by a Male patient taking Reyataz (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: UNITED STATES , 54 years of age, weighting 180.8 lb, Patient experienced the following unwanted or unexpected effects: nephrolithiasis. During the same period patient was treated with TRUVADA (View Truvada Review and Truvada Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), SUSTIVA (View Sustiva Review and Sustiva Label ).

6923908-1 | Jaundice, Vaginal Discharge
on May 25, 2010 Female patient from UNITED STATES , 33 years of age, was treated with Reyataz (View Usage). Patient had the following side effects: jaundice (What is jaundice?), vaginal discharge. Reyataz dosage: . During the same period patient was treated with TRUVADA (View Truvada Review and Truvada Label ), ISENTRESS (View Isentress Review and Isentress Label ).

6923907-X | Alopecia
on May 25, 2010 Female patient from UNITED STATES , 39 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Reyataz (View Usage). After Reyataz was administered, patient had the following side effects: alopecia. Reyataz dosage: . During the same period patient was treated with RITONAVIR (View Ritonavir Review and Ritonavir Label ), TRUVADA (View Truvada Review and Truvada Label ).

6923906-8 | Nephrolithiasis
Patient was taking Reyataz (View Usage). Patient experienced the following unwanted or unexpected effects: nephrolithiasis on May 25, 2010 from UNITED STATES Additional patient health information: Female patient , 40 years of age, . Reyataz dosage: . During the same period patient was treated with RITONAVIR (View Ritonavir Review and Ritonavir Label ).

6923905-6 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Bilirubin Increased
Adverse event was reported on May 28, 2010 by a Male patient taking Reyataz (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: UNITED STATES , 51 years of age, Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased. During the same period patient was treated with RITONAVIR (View Ritonavir Review and Ritonavir Label ), TRUVADA (Df=200/300(unit Not Specified)) (View Truvada Review and Truvada Label ).

6923902-0 | Pregnancy, Vomiting
on May 10, 2010 Female patient from UNITED STATES , 30 years of age, weighting 130.1 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Reyataz (View Usage). After Reyataz was administered, patient had the following side effects: pregnancy (What is pregnancy?), vomiting. Reyataz dosage: . During the same period patient was treated with EPZICOM (View Epzicom Review and Epzicom Label ).

6923895-6 | Dysgeusia, Product Odour Abnormal
on May 24, 2010 Female patient from UNITED STATES , 41 years of age, was treated with Reyataz (View Usage). Patient experienced the following unwanted or unexpected effects: dysgeusia, product odour abnormal. Reyataz dosage: 2df-2 Caps. During the same period patient was treated with EPZICOM (View Epzicom Review and Epzicom Label ).

6923894-4 | T-lymphocyte Count Decreased
Patient was taking Reyataz (View Usage). Patient had the following side effects: t-lymphocyte count decreased on May 17, 2010 from UNITED STATES Additional patient health information: Male patient , 65 years of age, weighting 127.9 lb, was diagnosed with hiv infection (What is hiv infection?), peripheral arterial occlusive disease and. Reyataz dosage: About 5 Yrs Ago. During the same period patient was treated with PLAVIX (About 1-? Years Ago) (View Plavix Review and Plavix Label ), NORVIR (View Norvir Review and Norvir Label ), COMBIVIR (View Combivir Review and Combivir Label ), SPIRIVA (View Spiriva Review and Spiriva Label ).

6923892-0 | Nephrolithiasis
Adverse event was reported on Apr 20, 2010 by a Male patient taking Reyataz (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: UNITED STATES , 48 years of age, weighting 178.6 lb, After Reyataz was administered, patient had the following side effects: nephrolithiasis. During the same period patient was treated with NORVIR (View Norvir Review and Norvir Label ), KALETRA (View Kaletra Review and Kaletra Label ), LEXAPRO (View Lexapro Review and Lexapro Label ), VICODIN ES (View Vicodin Es Review and Vicodin Es Label ), FLEXERIL (View Flexeril Review and Flexeril Label ), FLOMAX (View Flomax Review and Flomax Label ), FIORICET (View Fioricet Review and Fioricet Label ), NORVASC (View Norvasc Review and Norvasc Label ).

6923891-9 | Blood Bilirubin Increased
on Apr 16, 2010 Male patient from UNITED STATES , 45 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Reyataz (View Usage). Patient experienced the following unwanted or unexpected effects: blood bilirubin increased. Reyataz dosage: . During the same period patient was treated with NORVIR (View Norvir Review and Norvir Label ), TRUVADA (View Truvada Review and Truvada Label ).

6923889-0 | No Adverse Event
on Apr 19, 2010 Male patient from UNITED STATES , 42 years of age, was treated with Reyataz (View Usage). Patient had the following side effects: no adverse event. Reyataz dosage: 150 Mg For 1-2 Weeks; Now Taking 300mg. During the same period patient was treated with CRESTOR (View Crestor Review and Crestor Label ), EPZICOM (View Epzicom Review and Epzicom Label ), NORVIR (View Norvir Review and Norvir Label ).

6923887-7 | Nephrolithiasis
Patient was taking Reyataz (View Usage). After Reyataz was administered, patient had the following side effects: nephrolithiasis on May 11, 2010 from UNITED STATES Additional patient health information: Male patient , 48 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Reyataz dosage: .

6923885-3 | Abdominal Pain
Adverse event was reported on Apr 08, 2010 by a Female patient taking Reyataz (View Usage) (Dosage: ) was diagnosed with hiv test positive (What is hiv test positive?) and. Location: UNITED STATES , 18 years of age, weighting 110.2 lb, Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?). During the same period patient was treated with IRON (View Iron Review and Iron Label ).

6923884-1 | Jaundice, Nephrolithiasis
on Apr 29, 2010 Male patient from UNITED STATES , 38 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Reyataz (View Usage). Patient had the following side effects: jaundice (What is jaundice?), nephrolithiasis. Reyataz dosage: . During the same period patient was treated with NORVIR (View Norvir Review and Norvir Label ), TRUVADA (1 Df= 1 Tabs) (View Truvada Review and Truvada Label ).

6923881-6 | Abdominal Discomfort
on Mar 23, 2010 Female patient from UNITED STATES , 45 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Reyataz (View Usage). After Reyataz was administered, patient had the following side effects: abdominal discomfort. Reyataz dosage: . During the same period patient was treated with NORVIR (View Norvir Review and Norvir Label ).

6923880-4 | Dysphagia
Patient was taking Reyataz (View Usage). Patient experienced the following unwanted or unexpected effects: dysphagia on Mar 12, 2010 from UNITED STATES Additional patient health information: Male patient , 52 years of age, weighting 127.9 lb, was diagnosed with hiv infection (What is hiv infection?) and. Reyataz dosage: . During the same period patient was treated with TRUVADA (View Truvada Review and Truvada Label ).

6923876-2 | Rash
Adverse event was reported on Feb 16, 2010 by a Female patient taking Reyataz (View Usage) (Dosage: ) . Location: UNITED STATES , 38 years of age, Patient had the following side effects: rash (What is rash?).

6923875-0 | Pregnancy, Rash
on Feb 11, 2010 Female patient from UNITED STATES , 25 years of age, was treated with Reyataz (View Usage). After Reyataz was administered, patient had the following side effects: pregnancy (What is pregnancy?), rash (What is rash?). Reyataz dosage: . During the same period patient was treated with RITONAVIR (View Ritonavir Review and Ritonavir Label ), EPZICOM (1df- 1 Tab. Interrupted And Later Restarted.) (View Epzicom Review and Epzicom Label ), ISENTRESS (View Isentress Review and Isentress Label ).

6923873-7 | Nephrolithiasis
on Mar 30, 2010 Male patient from UNITED STATES , 45 years of age, was diagnosed with hiv test positive (What is hiv test positive?) and was treated with Reyataz (View Usage). Patient experienced the following unwanted or unexpected effects: nephrolithiasis. Reyataz dosage: . During the same period patient was treated with NORVIR (View Norvir Review and Norvir Label ), TRUVADA (View Truvada Review and Truvada Label ).

6923870-1 | Nephrolithiasis
Patient was taking Reyataz (View Usage). Patient had the following side effects: nephrolithiasis on Feb 15, 2010 from UNITED STATES Additional patient health information: Male patient , 38 years of age, . Reyataz dosage: For 3-74 Yrs. During the same period patient was treated with VIDEX (View Videx Review and Videx Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), TENOFOVIR DISOPROXIL FUMARATE (View Tenofovir Disoproxil Fumarate Review and Tenofovir Disoproxil Fumarate Label ).